Ligne de temps

Hélène Saklani
																												Ingénieur(e) de Recherche
																	15 août 2025
								publication
									Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control.
Lire plus24 sept. 2015
								publication
									RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Lire plus01 janv. 2013
								
							01 juin 2012
								publication
									Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer
Lire plus08 déc. 2011
								publication
									Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery
Lire plus20 févr. 2009
								publication
									Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells
Lire plus01 sept. 2008
								publication
									Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming
Lire plus15 juin 2006
								publication